| Employment |
| No Relationships to Disclose |
|
|
| Leadership |
| No Relationships to Disclose |
|
|
| Stock and Other Ownership Interests |
| No Relationships to Disclose |
|
|
| Honoraria |
| No Relationships to Disclose |
|
|
| Consulting or Advisory Role |
| Company: Iovance Biotherapeutics |
| Recipient: You |
| Company: Novartis |
| Recipient: You |
| Company: BluePath Solutions |
| Recipient: You |
| Company: Pfizer |
| Recipient: You |
| Company: Bristol-Myers Squibb/Medarex |
| Recipient: You |
| Company: immatics |
| Recipient: You |
| Company: Merck |
| Recipient: You |
| Company: Adaptimmune |
| Recipient: You |
| Company: IO Biotech |
| Recipient: You |
| Company: Genmab |
| Recipient: You |
| Company: Replimune |
| Recipient: You |
| Company: Obsidian Therapeutics |
| Recipient: You |
| Company: cTRL Therapeutics |
| Recipient: You |
|
| Speakers' Bureau |
| No Relationships to Disclose |
|
|
| Research Funding |
| Company: Obsidian Therapeutics |
| Recipient: You |
| Company: Replimune |
| Recipient: You |
| Company: Immunocore |
| Recipient: You |
| Company: immatics |
| Recipient: You |
| Company: Iovance Biotherapeutics |
| Recipient: Your Institution |
| Company: Bristol-Myers Squibb/Medarex |
| Recipient: Your Institution |
| Company: Lyell Immunopharma |
| Recipient: Your Institution |
|
| Patents, Royalties, Other Intellectual Property |
| No Relationships to Disclose |
|
|
| Expert Testimony |
| No Relationships to Disclose |
|
|
| Travel, Accommodations, Expenses |
| No Relationships to Disclose |
|
|
| Other Relationship |
| No Relationships to Disclose |
|
|
| (OPTIONAL) Uncompensated Relationships |
| No Relationships to Disclose |
|
|
| (OPTIONAL) Open Payments Link |
| No Relationships to Disclose |
|
|